- Visibility 292 Views
- Downloads 311 Downloads
- Permissions
- DOI 10.18231/j.ijmmtd.v.11.i.3.19
-
CrossMark
- Citation
Prevalence of HBsAg infection and treatment predictors in HBsAg-positive patients at tertiary care center
Background: HBV infection is a global public health challenge, contributing significantly to liver-related morbidity and mortality. This study, conducted at a tertiary care center, aimed to decide the prevalence of HBV using ELISA test, assess Hepatitis B virus viral load in HBsAg-positive patients, and evaluate predictors of treatment response in those receiving antiviral therapy.
Materials and Methods: This study included 42000 samples from suspected cases of viral Hepatitis for HbsAg antigen testing. The samples were checked for presence of HBsAg antigen by 3rd generation ELISA. The samples positive for HBV infection were then tested for HBV DNA by quantitative RT-PCR test.
Results: Total 42,000 samples of patients were taken for testing for HBsAg Antigens by Enzyme-Linked Immunosorbent Assay, 620 (1.47%) were seropositive. Out of 620 samples, 122 samples had taken testing for the presence of HBV DNA level by real time RT-PCR. Out of 122 samples, 102 samples were detected positive for HBV DNA and 20 were detected negative by PCR. Out of 102 HBV DNA positive samples, 44 samples had HBV DNA level <20,000 IU/ml and 58 samples had HBV DNA level >20,000 IU/ml.
Conclusion: Hepatitis B is continued to be serious global threat with long term complication. In developing countries HBV is a major cause of mortality and morbidity. HBV RT-PCR has high sensitivity & specificity for detecting active infection and monitoring response to treatment.
References
- World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at: https://www.who.int/publications/i/item/9789240027077
- Villa DF, Maria-Cristina N. Vertical Transmission of Hepatitis B Virus—An Update. Microorganisms. 2023;11(5):1140.
- Puri P. Tackling the hepatitis B disease burden in India. J Clin Exp Hepatol. 2014;4(4):312–9.
- Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63.
- Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002;122(5):1554–68.
- Singh B, Jayant S, Dehariya R, Poddar A, Bajpai T. Seroprevalence of Hepatitis B Virus infection in patients visiting a tertiary care hospital in Central India. Int J Health Clin Res. 2021;4(14):130–2.
- Narvade PP, More SR, Kandle SK, Rathod VS, Emekar SM. Seroprevalence of Hepatitis B Surface Antigen (HBsAg) among Patients Attending a tertiary Care Hospital. Int J Curr Microbiol App Sci. 2019;8(3):1014–8.
- Patil SR, Ghorpade M, Patil SS, Pawar S, Mohite S. Seroprevalence of Hepatitis-B Surface antigen among the patients reporting at tertiary care Hospital from India. Bangladesh J Med Sci. 2016;15(3)::455–9. Bhadreshwara et al. / IP International Journal of Medical Microbiology and Tropical Diseases 2025;11(3):352-357 357
- Naik TB, Satish JV, Wadekar MD. Seroprevalence of Hepatitis B Surface Antigen (HBsAg) among Patients Attending a tertiary Care Hospital at Chamarajanagar, Karnataka, India. Int J Curr Microbiol App Sci. 2018;7(1):1279–84.
- Kumar M, Verma RK, Nirjhar S, Singh M. Seroprevalence of Hepatitis B at tertiary Care Hopital. Ann Int Med Den Res. 2019;5(3):5–8
- Mandell GL, Bennett JE, Churchill DR. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Edition 9th. Livingstone. 2020;2040–70.
- Patel PH, Nerurkar AB, Patel MR. Seroprevalence of Hepatitis B Surface Antigen in patients attending a tertiary care hospital Valsad, South Gujarat, India. Int J Med Microbiol Trop Dis. 2016;2(3):103–
- Elahi W, Syed AZ, Nasim F, Anwar A, Hashmi AA. Hepatitis B and C Infections in Patients with Prolonged Hemodialysis Secondary to Chronic Renal Failure. Cureus. 2020;12(10):e10905.
- Raina D, Rawat N, Ajay K. Pandita. Prevalence of Hepatitis B and Hepatitis C in patients Undergoing hemodialysisi at teaching hospital in Uttarakhand. J Family Med Prim Care . 2022;11(4):1348–53.
- Kumar A, Pant S, Narang S. Significance of alanine aminotransferase testing in diagnosis of acute and chronic HBV infection. Asian Pac J Cancer Prev. 2009;10(6):1171–2.
- Nita ME, Gaburo N, Cheinquer H, L'Italien G, Affonso de Araujo ES, Mantilla P, et al. Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status. Ann Hepatol. 2009;8(4):339–45.
- Iregbu KC, Nwajiobi-Princewill PI. Viral load pattern among hepatitis B surface antigen-positive patients: Laboratory perspective and implications for therapy. Ann Med Health Sci Res. 2016;6(2):95–9
- Anjum Q. False positive Hepatitis B Surface Antigen due to recent vaccination. Int J Health Sci (Qassim). 2014;8(2):189–93.
How to Cite This Article
Vancouver
Bhadreshwara VB, Gadhavi HM, Shingala HK. Prevalence of HBsAg infection and treatment predictors in HBsAg-positive patients at tertiary care center [Internet]. IP Int J Med Microbiol Trop Dis. 2025 [cited 2025 Oct 17];11(3):352-357. Available from: https://doi.org/10.18231/j.ijmmtd.v.11.i.3.19
APA
Bhadreshwara, V. B., Gadhavi, H. M., Shingala, H. K. (2025). Prevalence of HBsAg infection and treatment predictors in HBsAg-positive patients at tertiary care center. IP Int J Med Microbiol Trop Dis, 11(3), 352-357. https://doi.org/10.18231/j.ijmmtd.v.11.i.3.19
MLA
Bhadreshwara, Vaishali Bhupatbhai, Gadhavi, Hiral M, Shingala, Hitesh K. "Prevalence of HBsAg infection and treatment predictors in HBsAg-positive patients at tertiary care center." IP Int J Med Microbiol Trop Dis, vol. 11, no. 3, 2025, pp. 352-357. https://doi.org/10.18231/j.ijmmtd.v.11.i.3.19
Chicago
Bhadreshwara, V. B., Gadhavi, H. M., Shingala, H. K.. "Prevalence of HBsAg infection and treatment predictors in HBsAg-positive patients at tertiary care center." IP Int J Med Microbiol Trop Dis 11, no. 3 (2025): 352-357. https://doi.org/10.18231/j.ijmmtd.v.11.i.3.19